Oscar Health, Inc. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Oscar Health, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q1 2024.
  • Oscar Health, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$79K, a 56.8% increase year-over-year.
  • Oscar Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $58K.
  • Oscar Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$165K, a 63.4% decline from 2021.
  • Oscar Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$101K, a 50.7% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$79K +$104K +56.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 -$183K -$183K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $0 -$8K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $8K -$112K -93.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $120K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.